IBRX241101P4000
- 0.03
- +0.01+50.00%
ImmunityBio Newsroom
Penny Stock Trades: Joby Aviation and ImmunityBio
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
ImmunityBio (IBRX) Soars 26.4%: Is Further Upside Left in the Stock?
Trump Media & Tech, ImmunityBio, And IRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?
Jeff Bezos Ends Washington Post's 36-Year Tradition Of Endorsements, Leaving Staff 'Roiled'
ImmunityBio Options Spot-On: On October 25th, 102.68K Contracts Were Traded, With 157.27K Open Interest
ImmunityBio Soars 56% in a Day: Is This Cancer Breakthrough the Next $30 Stock?
Top Midday Gainers
Booz Allen Posts Upbeat Q3 Earnings, Joins Deckers Outdoor, Saia, Boyd Gaming And Other Big Stocks Moving Higher On Friday
IBRX Soars 47% on Initial Trials For Cell Therapy Product
Sector Update: Health Care Stocks Decline Friday Afternoon
12 Health Care Stocks Moving In Friday's Intraday Session
ImmunityBio Shares Jump After First Patients Dosed in Phase 1 Study for Potential Non-Hodgkin's Lymphoma Treatment
ImmunityBio Extends Gains After Trial Update
Top 2 Health Care Stocks That May Fall Off A Cliff This Month
Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Express News | Shares Of ImmunityBio, See Volume; Barron's Article, "This Biotech Stock Could Rocket 800%, Analyst Says"
ImmunityBio: 1st Patient Dosed in CAR-NK Cell Therapy Study Relapsed NHL
Express News | Immunitybio Inc: Complete Enrollment Currently Expected in Q1 2025